Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

OBJECTIVE: Cognitive decline occurs in multiple neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Shared underlying mechanisms may exist and manifest as shared biomarker signatures. Previously, we nominated plasma epidermal growth factor (EGF) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Nicholas S., Swanson, Christine R., Cherng, Hua‐Ren, Unger, Travis L., Xie, Sharon X., Weintraub, Daniel, Marek, Ken, Stern, Matthew B., Siderowf, Andrew, Trojanowski, John Q., Chen‐Plotkin, Alice S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863747/
https://www.ncbi.nlm.nih.gov/pubmed/27231704
http://dx.doi.org/10.1002/acn3.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863747/
https://www.ncbi.nlm.nih.gov/pubmed/27231704
http://dx.doi.org/10.1002/acn3.299

Ejemplares similares